• Progen Pharmaceuticals Ltd.. is located in Brisbane, Australia. The location was incorrect in an item in the Aug. 16 issue.

• An article in the Aug. 16 issue of BioWorld Today incorrectly stated that researchers used Elan's anti-amyloid beta antibody bapineuzumab to reduce glaucoma-caused apoptosis in animal studies. The story should have said that the researchers used a research antibody that targets amyloid-beta.

These corrections have been made in BioWorld Online.